William Bauer
Neurology · Bellevue, OHNPI 1316931942
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 74.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $8,480 and has fallen 98.7% since, to $114 in 2022.
Across 165 payments — averaging $54.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$7K
- Sanofi$432
- Novartis$231
- Collegium Pharmaceutical, Inc.$194
- Supernus Pharmaceuticals, Inc.$173
- Mallinckrodt Enterprises LLC$145
- plus $1K from 18 others
Across 10 payments — averaging $2531.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Enterprises LLC$16K
- Biogen$9K
- Novartis$433
What the payments were for
- Speaking & faculty fees$5,04856%
- Travel & lodging$1,08612%
- Food & beverage$2,86732%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 45 | $6,691 |
| Sanofi | 9 | $432 |
| Novartis | 25 | $231 |
| Collegium Pharmaceutical, Inc. | 20 | $194 |
| Supernus Pharmaceuticals, Inc. | 26 | $173 |
| Mallinckrodt Enterprises LLC | 4 | $145 |
| Genentech USA, Inc. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 4 | $126 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $114 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| UCB, Inc. | 2 | $77 |
| AstraZeneca | 3 | $52 |
| Acorda Therapeutics, Inc | 3 | $48 |
| AbbVie(2 entities) | 3 | $46 |
| Pfizer | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| EMD Serono, Inc. | 1 | $21 |
| GE HealthCare | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Greenwich Biosciences, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,009 in reported general payments places this provider in the 75th percentile of 702 neurology providers in Ohio.
Other neurology in Bellevue
- Christopher HassettBellevue$270K
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Lawrence ElmerToledo$687K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
- Geoffrey EubankColumbus$508K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.